Type:

Managing cow’s-milk protein allergy in infants and children. Updates from 2023 4th March 2024

The World Allergy Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition both updated their guidelines for managing cow’s milk protein allergy in infants and children in 2022-2023. This paper in Global Pediatrics summarises the main points of these new guidelines and the debates around some of them.

Read more
New research finds introducing peanut into the diets of high-risk infants is largely successful 16th February 2024

A US study has found that only 2% of high-risk infants developed peanut allergy after introduction of peanuts into their diet. The results support other studies showing low rates of new allergies after early introduction of peanut but demonstrate the need for extra guidance, reassurance and support, especially if others in the family have a peanut allergy.

Read more
Do you have an allergy to either peanuts, seafood, or bee/wasp stings, that requires use of an EpiPen?  15th February 2024

Do you have an allergy to either peanuts, seafood, or bee/wasp stings, that requires use of an EpiPen?  The University of Manchester is looking for a member of the public who can give a patient’s perspective of allergies to a group of master’s students who are studying the immune system.

Read more
Research highlights from 2023 6th February 2024

2023 was a year of great progress in research, with new treatments, prevention strategies and improvements in diagnostic tests on the horizon. We look back at some of the highlights.

Read more
New trial of peanut sublingual immunotherapy completes first stage 26th January 2024

ALK have announced that it has completed the first part of its phase 1 clinical trial known as ALLIANCE for a new immunotherapy tablet for peanut allergy. The trial will now progress into its second part, expected to complete later in 2024.

Read more
Novartis ends food allergy drug trial but plans new trial at revised dose 26th January 2024

Novartis, the Swiss pharmaceutical company, has halted its phase 3 study of the biologic drug ligelizumab for peanut allergy this January, but plans to launch a new study at a different dose. If approved, the study will begin in Autumn 2024.

Read more
More research to support early introduction of allergic food before 12 months 21st December 2023

A new review of the existing evidence, published in the British Medical Journal (the BMJ), has found that introducing allergen-containing food to infants’ diets from the age of 4 to 12 months was associated with a lower risk of multiple food allergies and eczema.

Read more
Do you have a child with a food allergy? Research participants needed 18th December 2023

Researchers from the Aston University aim to explore potential predictors of anxiety and quality of life in parents of children with food allergies, with intentions of gaining a greater understanding surrounding the complexities of caring for children with these medical needs.

Read more
Do you care for a child with multiple allergies? An invitation to take part in research 18th December 2023

Researchers from the University of Aston are looking for parents and carers of children with a food allergy and either asthma, eczema or allergic rhinitis to talk about their experiences in a new study, aiming to improve understanding and support for caregivers.

Read more